AEROVATE THERAPEUTICS INC (AVTE) Stock Balance Sheet
NASDAQ:AVTE - Nasdaq - US0080641071 - Common Stock - Currency: USD
| MRQ (2024-9-30) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash | N/A | N/A | 22.40M | 54.20M | 4.60M | |||
| Cash Equivalents | 31.11M | 23.49M | N/A | N/A | N/A | |||
| Marketable Securities | 57.62M | 98.95M | 106.80M | 113.20M | N/A | |||
| Other Current Assets | 1.88M | 1.79M | 2.30M | 7.00M | 100.00K | |||
| Total Current Assets | 90.61M | 124.23M | 131.50M | 174.30M | 4.70M | |||
| Non-Current Assets | ||||||||
| PPE Net | 273.00K | 902.00K | 1.20M | 700.00K | 0.00 | |||
| Other Non-Current Assets | 81.00K | 2.28M | 2.60M | 300.00K | N/A | |||
| Total Non-Current Assets | 354.00K | 3.19M | 3.80M | 1.10M | 0.00 | |||
| TOTAL ASSETS | 90.96M | 127.42M | 135.30M | 175.40M | 4.70M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 8.41M | 14.07M | 4.80M | 1.20M | 1.10M | |||
| Accounts Payable | 908.00K | 2.40M | 2.60M | 1.20M | 600.00K | |||
| Other Current Liabilities | 993.00K | 1.17M | 400.00K | 100.00K | 0.00 | |||
| Total Current Liabilities | 10.31M | 17.64M | 7.80M | 2.60M | 1.80M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 151.00K | 325.00K | 800.00K | 400.00K | N/A | |||
| Total Non-Current Liabilities | 151.00K | 325.00K | 800.00K | 300.00K | 0.00 | |||
| TOTAL LIABILITIES | 10.47M | 17.96M | 8.60M | 2.90M | 1.80M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -227.62M | -163.42M | -87.90M | -36.40M | -13.40M | |||
| Additional Paid In Capital | 307.89M | 272.64M | 215.10M | 208.90M | 100.00K | |||
| Common Shares | 3.00K | 3.00K | 0.00 | 0.00 | 16.30M | |||
| Other Shareholders' Equity | 224.00K | 237.00K | -500.00K | -100.00K | N/A | |||
| Shares Outstanding | 28.87M | 27.76M | 24.70M | 24.40M | 23.10M | |||
| Tangible Book Value per Share | 2.79 | 3.94 | 5.13 | 7.07 | -0.58 | |||
| Total Shareholders' Equity | 80.49M | 109.46M | 126.70M | 172.40M | 2.90M | |||
| TOTAL LIABILITIES AND EQUITY | 90.96M | 127.42M | 135.30M | 175.40M | 4.70M | |||
| Statistics | ||||||||
| Debt/Equity | N/A | N/A | N/A | N/A | N/A | |||
| Current Ratio | 8.78 | 7.04 | 16.86 | 67.04 | 2.61 | |||
| Return On Assets (ROA) | -93.02% | -59.27% | -38.07% | -13.11% | -207.66% | |||
| Return On Equity (ROE) | -105.12% | -69.00% | -40.66% | -13.34% | -336.55% | |||
All data in USD , ROIC based on taxRate of 0.21